Enveric Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.55 | -$0.55 | -$0.55 |
| Q2 2024 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q3 2024 | 1 | -$0.40 | -$0.40 | -$0.40 |
| Q1 2025 | 1 | -$0.40 | -$0.40 | -$0.40 |
| Q2 2025 | 1 | -$0.35 | -$0.35 | -$0.35 |
| Q3 2025 | 1 | -$0.35 | -$0.35 | -$0.35 |
| Q4 2025 | 1 | -$0.31 | -$0.31 | -$0.31 |
Enveric Biosciences, Inc. Earnings Date And Information
Enveric Biosciences, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.25 earnings per share for the quarter, topping analysts' consensus estimates of $-0.55 by $0.3. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Enveric Biosciences, Inc. has generated $-8 earnings per share over the last year ($-8.09 diluted earnings per share) and currently has a price-to-earnings ratio of -0.3. Enveric Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 24th, 2025 based on prior year's report dates.
Enveric Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.24 | $0 | $0 | ||
| 08/12/2024 | Q2 2024 | -$0.55 | -$0.25 | 0.3 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$0.61 | $0 | |||
| 03/25/2024 | Q4 2023 | -$1.46 | $647,092 | |||
| 11/13/2023 | Q3 2023 | -$1.93 | -$1.30 | 0.63 | $0 | |
| 08/11/2023 | Q2 2023 | -$3.02 | $0 | |||
| 05/15/2023 | Q1 2023 | -$2.22 | $0 | |||
| 06/08/2023 | Q4 2022 | -$6.76 | $0 | |||
| 11/14/2022 | Q3 2022 | -$4.00 | $0.38 | 4.38 | $0 | |
| 08/12/2022 | Q2 2022 | -$3.83 | -$0.84 | 2.99 | $0 | |
| 05/13/2022 | Q1 2022 | -$8.00 | -$5.01 | 2.99 | $0 | |
| 03/31/2022 | Q4 2021 | -$90.97 | $0 | |||
| 11/12/2021 | Q3 2021 | -$8.00 | -$5.91 | 2.09 | $0 | |
| 08/13/2021 | Q2 2021 | -$8.75 | -$2.13 | 6.62 | $0 | |
| 05/17/2021 | Q1 2021 | -$10.02 | $0 | |||
| 04/01/2021 | Q4 2020 | -$236.69 | $-26,340,499 | |||
| 11/16/2020 | Q3 2020 | -$8.20 | $8.48 M | |||
| 08/14/2020 | Q2 2020 | -$13.87 | $8.25 M | |||
| 05/15/2020 | Q1 2020 | -$112.41 | $9.60 M | |||
| 03/25/2020 | Q4 2019 | -$235.12 | $9.06 M |
Enveric Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Enveric Biosciences, Inc.'s earnings date?
Enveric Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 24th, 2025 based off last year's report dates.
-
Did Enveric Biosciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Enveric Biosciences, Inc. (:ENVB) reported $-0.25 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.55 by $0.3.
-
How can I listen to Enveric Biosciences, Inc.'s earnings conference call?
The conference call for Enveric Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Enveric Biosciences, Inc.'s conference call transcript?
The conference call transcript for Enveric Biosciences, Inc.'s latest earnings report can be read online.
-
How much profit does Enveric Biosciences, Inc. generate each year?
Enveric Biosciences, Inc. (:ENVB) has a recorded net income of $0. Enveric Biosciences, Inc. has generated $-8.09 earnings per share over the last four quarters.
-
What is Enveric Biosciences, Inc.'s price-to-earnings ratio?
Enveric Biosciences, Inc. (:ENVB) has a price-to-earnings ratio of -0.3 and price/earnings-to-growth ratio is -0.01.
